These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8828022)

  • 1. Clinical studies of the efficacy and tolerability of ebastine 10 or 20 mg once daily in the treatment of seasonal allergic rhinitis in the US.
    Storms WW
    Drugs; 1996; 52 Suppl 1():20-5. PubMed ID: 8828022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis. The Ebastine Study Group.
    Ratner PH; Lim JC; Georges GC
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1101-7. PubMed ID: 10856142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative clinical studies with ebastine: efficacy and tolerability.
    Luria X
    Drug Saf; 1999; 21 Suppl 1():63-7; discussion 81-7. PubMed ID: 10597869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
    Hampel F; Howland W; Van Bavel J; Ratner P
    J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.
    Gehanno P; Bremard-Oury C; Zeisser P
    Ann Allergy Asthma Immunol; 1996 Jun; 76(6):507-12. PubMed ID: 8673684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
    Bousquet J; Gaudaño EM; Palma Carlos AG; Staudinger H
    Allergy; 1999 Jun; 54(6):562-8. PubMed ID: 10435469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the efficacy of ebastine 10mg and 20mg once daily with that of cetirizine 10mg once daily in adults with seasonal allergic rhinitis. A multicentre double-blind study.
    Cohen B; Gehanno P
    Drugs; 1996; 52 Suppl 1():26-9. PubMed ID: 8828023
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical efficacy of ebastine in the treatment and prevention of seasonal allergic rhinitis.
    Peláez A
    Drugs; 1996; 52 Suppl 1():35-8. PubMed ID: 8828025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
    Murris-Espin M; Melac M; Charpentier JC; Didier A
    Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of ebastine in the control of nasal congestion associated with allergic rhinitis.
    Ratner P; Hampel F; Gispert J
    Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):111-5. PubMed ID: 12731456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
    Ratner P; Falqués M; Chuecos F; Esbrí R; Gispert J; Peris F; Luria X; Rosales MJ
    Int Arch Allergy Immunol; 2005 Dec; 138(4):312-8. PubMed ID: 16224195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study.
    Ratner P; Hampel F; Van Bavel J; Howland W
    Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
    Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
    Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled study of the efficacy and tolerability of ebastine against hayfever in general practice patients.
    Ankier SI; Warrington SJ
    J Intern Med; 1989 Dec; 226(6):453-8. PubMed ID: 2577377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
    Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
    Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of the efficacy and safety of ebastine 20 mg once daily given with and without food in the treatment of seasonal allergic rhinitis.
    Frank H; Gillen M; Rohatagi SS; Lim J; George G;
    J Clin Pharmacol; 2002 Oct; 42(10):1097-104. PubMed ID: 12362923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
    Sastre J
    Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders.
    Wiseman LR; Faulds D
    Drugs; 1996 Feb; 51(2):260-77. PubMed ID: 8808167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind multicentre comparative study of ebastine, terfenadine and placebo in the treatment of chronic idiopathic urticaria in adults.
    Kalis B
    Drugs; 1996; 52 Suppl 1():30-4. PubMed ID: 8828024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of azelastine nasal spray and oral ebastine in treating seasonal allergic rhinitis.
    Conde Hernández DJ; Palma Aqilar JL; Delgado Romero J
    Curr Med Res Opin; 1995; 13(6):299-304. PubMed ID: 8829888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.